Related Experiment Video
Updated: Jul 4, 2026

A Method for Generating Pulmonary Neutrophilia Using Aerosolized Lipopolysaccharide
Published on: December 15, 2014
Nanoparticle-Mediated "Cut-Off and Clean-Up" Strategy for Neutrophil Manipulation in Acute Lung Injury Therapy
Jiaxin Li1, Yeyi Hu1, Shuang Chen1
1Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, China.
Abstract:
Polymorphonuclear neutrophils (PMNs) are pivotal in acute lung injury (ALI) due to their uncontrollable infiltration and intense inflammatory response. Therefore, we proposed a "cut-off and clean-up" strategy to manipulate PMNs for ALI treatment. To "cut off PMN supply", we consider occupying their binding sites on inflamed endothelium by targeting P-selectin. To precisely "clean up PMNs", we consider specifically inducing their apoptosis and minimizing damage to endothelium and pulmonary parenchyma. Thus, we constructed S-DE/GD, consisting of liposomes containing 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE), sulfated hyaluronic acid (SHA) surface modification, and encapsulating glucose-modified doxorubicin (GD). For circulating PMNs, SHA with high P-selectin affinity can inhibit their infiltration. For infiltrated PMNs, the cleanup process involves two steps. First, GD escapes from endosomes utilizing DOPE and is then exocytosed into the lungs through the unidirectional transport of glucose. Subsequently, extruded GD is selectively taken up by infiltrated PMNs overexpressing glucose transporter-1. In ALI mouse model, S-DE/GD demonstrated significant therapeutic efficacy, indicating its potential as a promising strategy for ALI treatment.
Insights
This study introduces a novel "cut-off and clean-up" strategy using S-DE/GD nanoparticles to treat acute lung injury (ALI). The approach targets polymorphonuclear neutrophils (PMNs) to reduce inflammation and improve therapeutic outcomes.
Area of Science:
- Biomedical Engineering
- Nanomedicine
- Immunology
Background:
- Polymorphonuclear neutrophils (PMNs) drive acute lung injury (ALI) through uncontrolled infiltration and inflammation.
- Targeting PMN activity is crucial for effective ALI treatment.
Purpose of the Study:
- To develop a novel therapeutic strategy for ALI by manipulating PMN behavior.
- To design S-DE/GD nanoparticles for targeted PMN inhibition and clearance.
Main Methods:
- Constructed S-DE/GD nanoparticles with liposomes, sulfated hyaluronic acid (SHA), and glucose-modified doxorubicin (GD).
- Utilized SHA to inhibit PMN infiltration by targeting P-selectin.
- Engineered GD for endosomal escape and selective uptake by PMNs via glucose transporter-1.
Main Results:
- S-DE/GD nanoparticles effectively inhibited PMN infiltration in an ALI mouse model.
- Demonstrated significant therapeutic efficacy in treating ALI.
- The strategy successfully reduced PMN-driven inflammation and lung damage.
Conclusions:
- The
- cut-off and clean-up
- strategy using S-DE/GD shows promise for ALI treatment.
- Targeted PMN manipulation offers a new avenue for managing inflammatory lung diseases.
Related Concept Videos
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Flail Chest-II
Assessment:
1. Clinical Evaluation:
History:

